FDA Panel Recommends Full Approval For Pfizer's COVID-19 Drug Paxlovid

The U.S. Food and Drug Administration's Antimicrobial Drugs Advisory Committee voted in favor of recommending a full approval for Pfizer Inc's (PFE) COVID-19 pill Paxlovid in adults at high risk of progression to severe disease, the company said in a statement.

The company noted that the Committee voted 16 to 1 that available data support the safety and effectiveness of Paxlovid (nirmatrelvir tablets and ritonavir tablets) for the treatment of mild-to-moderate COVID-19 in adult patients who are at high risk for progression to severe illness.

The Committee's vote, while not binding, will be considered by the FDA when making its decision regarding the potential approval of Paxlovid.

If approved by the FDA, Paxlovid could be the first U.S. FDA-approved oral treatment for COVID-19. The target Prescription Drug User Fee Act (PDUFA) action date for a decision by the FDA is May 2023, the company said.

Under the FDA emergency use authorization, Paxlovid is currently authorized for use in, and remains available to, adults and pediatric patients at high risk of progression to severe COVID-19.

Pfizer said it continues to gather pediatric data from the ongoing clinical trial EPIC-Peds and intends to submit a supplemental New Drug Application to support the FDA approval of Paxlovid in children at a future date.

In February 2023, the European Commission granted standard Marketing Authorization of Paxlovid for the treatment of COVID-19 in adults who do not require supplemental oxygen and who are at increased risk of the disease becoming severe.

For More Such Health News, visit rttnews.com

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Massachusetts-based TJX Companies Inc. is recalling about 10,850 units of Haining Degao Benches citing fall risk, the U.S. Consumer Product Safety Commission said. The recall involves benches with a cushion top and four wooden legs that screw into the bench. The cushion top was sold in navy, gray, cream, white and yellow. "HAINING DEGAO HOME FURNISHINGS CO., LTD." and "MADE IN CHINA" are printed Chicago, Illinois -based Regal Health Food International, Inc. is recalling Regal Gourmet Snacks Milk Chocolate Raisins as it may contain undeclared peanuts, a known allergen, the U.S. Food and Drug Administration said. The recalled products were distributed through Dollar General retail stores. GameStop Corp. Wednesday disclosed that its Board of Directors has elected Chairman Ryan Cohen as Executive Chairman, effective immediately. In a filing with the U.S. Securities and Exchange Commission, the video game retailer said its Board on June 5 terminated Matthew Furlong as President and Chief Executive Officer with immediate effect.
Follow RTT